When to initiate combined antiretroviral therapy to reduce the mortality of HIV-infected individuals

By:

Cain, L.E

Contributor(s): Publication details: 2011ISSN:

00034819

Uniform titles:

Annals of internal medicine.

Online resources:

Click here to access online

Summary: <h3>BACKGROUND : Most clinical guidelines recommend that AIDS-free, HIV-infected personswith CD4 cell counts below 0.350 × 10(9) cells/L initiate combined antiretroviral therapy(cART), but the optimalCD4 cell count at which cART should be initiated remains a matter of debate.</h3><h4>OBJECTIVE : To identify the optimal CD4 cell count at which cART should be initiated.</h4><h4>DESIGN : Prospective observational data from the HIV-CAUSAL Collaboration anddynamic marginal structural models were used to compare cART initiationstrategies for CD4 thresholds between 0.200 and 0.500 × 10(9) cells/L.</h4><h4>SETTING : HIV clinics in Europe and the Veterans HealthAdministration system in the United States.</h4><h4>PATIENTS : 20, 971 HIV-infected, therapy-naivepersons with baseline CD4 cell counts at or above 0.500 × 10(9) cells/L and noprevious AIDS-defining illnesses, of whom 8392 had a CD4cell count that decreased into the range of 0.200 to 0.499 × 10(9) cells/L andwere included in the analysis.</h4><h4>MEASUREMENTS : Hazard ratios andsurvival proportions for all-cause mortality and a combined end point ofAIDS-defining illness or death.</h4><h4>RESULTS : Compared with initiating cART at the CD4cell count threshold of 0.500 × 10(9) cells/L, the mortality hazard ratio was1.01 (95% CI, 0.84 to 1.22) for the 0.350 threshold and 1.20 (CI, 0.97 to 1.48)for the 0.200 threshold. The corresponding hazard ratios were 1.38 (CI, 1.23 to1.56) and 1.90 (CI, 1.67 to 2.15), respectively, for the combinedend point of AIDS-defining illness or death. Limitations: CD4 cell count at cARTinitiation was not randomized. Residual confounding may exist.</h4><h4>CONCLUSION : Initiation of cART at a threshold CD4count of 0.500 × 10(9) cells/L increases AIDS-free survival. However, mortalitydid not vary substantially with the use of CD4 thresholds between 0.300 and0.500 × 10(9) cells/L.</h4>

Holdings
Item type	Home library	Collection	Class number	Status	Date due	Barcode
UNKNOWN	Ferriman information and Library Service (North Middlesex) Online	Staff publications for NMDX		Available

NMUH Staff Publications

154

<h3>BACKGROUND : Most clinical guidelines recommend that AIDS-free,&nbsp;HIV-infected personswith CD4 cell counts below 0.350 × 10(9) cells/L initiate combined&nbsp;antiretroviral&nbsp;therapy(cART), but the optimalCD4 cell count at which cART should be initiated remains a matter of debate.</h3><h4>OBJECTIVE : To identify the optimal CD4 cell count at which cART should be initiated.</h4><h4>DESIGN : Prospective observational data from the&nbsp;HIV-CAUSAL Collaboration anddynamic marginal structural models were used to compare cART initiationstrategies for CD4 thresholds between 0.200 and 0.500 × 10(9) cells/L.</h4><h4>SETTING : HIV&nbsp;clinics in Europe and the Veterans HealthAdministration system in the United States.</h4><h4>PATIENTS : 20, 971&nbsp;HIV-infected, therapy-naivepersons with baseline CD4 cell counts at or above 0.500 × 10(9) cells/L and noprevious AIDS-defining illnesses, of whom 8392 had a CD4cell count that decreased into the range of 0.200 to 0.499 × 10(9) cells/L andwere included in the analysis.</h4><h4>MEASUREMENTS : Hazard ratios andsurvival proportions for all-cause mortality and a combined end point ofAIDS-defining illness or death.</h4><h4>RESULTS : Compared with initiating cART at the CD4cell count threshold of 0.500 × 10(9) cells/L, the mortality hazard ratio was1.01 (95% CI, 0.84 to 1.22) for the 0.350 threshold and 1.20 (CI, 0.97 to 1.48)for the 0.200 threshold. The corresponding hazard ratios were 1.38 (CI, 1.23 to1.56) and 1.90 (CI, 1.67 to 2.15), respectively, for the combinedend point of AIDS-defining illness or death. Limitations: CD4 cell count at cARTinitiation was not randomized. Residual confounding may exist.</h4><h4>CONCLUSION : Initiation of cART at a threshold CD4count of 0.500 × 10(9) cells/L increases AIDS-free survival. However, mortalitydid not vary substantially with the use of CD4 thresholds between 0.300 and0.500 × 10(9) cells/L.</h4>

There are no comments on this title.

to post a comment.

Storage	Name	Value	Expiration	Description
Cookie	CGISESSID	Session ID	Until logout or end of session	Session cookie
Cookie	KohaOpacLanguage	Language code	3 years	Stores the language the user selected, so the online catalog will appear in that same language the next time it is visited.
Cookie	form_serialized form_serialized_limits	Search terms and limits	End of session or when the advanced search page is accessed again.	jQuery cookie. Stores search terms and limits of the last advanced search. Set when an advanced search is submitted.
Cookie	search_path_code	ads (fewer) or exs (more)	End of session or when the advanced search page is accessed again.	jQuery cookie. Related to serialized_form* cookies. Stores if the advanced search form was used with 'More options' or 'Fewer options'.
Cookie	num_paragraph	Count of search options added	End of session or when the advanced search page is accessed again.	jQuery cookie. Used to store the number of created options when user selects 'More options' in advanced search to increase search boxes.
Cookie	bib_list	List of record IDs (biblionumbers) separated by /	End of session or until the cart is emptied.	Stores cart contents in the online catalog. Set when records are added to the cart for the first time.